AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Physicians’ Education Resource® Presents the 20th Annual International Lung Cancer Congress®

May 6, 2019

CRANBURY, N.J.--(BUSINESS WIRE)--May 6, 2019--Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education, will host the 20th Annual International Lung Cancer Congress® from July 25 to 27 at the Huntington Regency Huntington Beach in California. The program will be chaired by  Dr.David R. Gandara, professor of medicine in the division of hematology/oncology at the University of California (UC) at Davis School of Medicine and the director of the thoracic oncology program and senior adviser to the director at UC Davis Comprehensive Cancer Center, and Dr.   Roy S. Herbst, Ensign professor of medicine (medical oncology), professor of pharmacology, chief of medical oncology and associate director for translational research at Yale Cancer Center, Yale School of Medicine.

“We are excited to celebrate 2 decades of educational excellence with this year’s upcoming International Lung Cancer Congress®,” said Phil Talamo, president of PER®. “Now in its 20th year, the congress has become one of the most comprehensive and detailed educational lung cancer meetings in the world, with national and international faculty sharing perspectives on evolving data, discussing new patient management strategies, and reflecting on the evidence that drives the future treatment of lung cancer.”

The 20th Annual International Lung Cancer Congress® is a three-day program for surgical, medical and radiation oncologists interested in the treatment of patients with lung cancer. During this meeting, leading international and national experts will provide perspectives on how to incorporate the latest data on targeted agents, immunotherapy, surgery and radiation oncology in the clinic through a series of cutting-edge lectures, panel discussions, multidisciplinary tumor boards and interactive Q&A sessions. Attendees who participate will have the opportunity to engage with faculty as they share their perspectives and personal experiences on the clinical challenges and ongoing controversies in lung cancer management.

For more information and to register, click here.

About Physicians’ Education Resource ® (PER ® )

Since 1995, PER ® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER ® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside oncology, PER ® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005686/en/

CONTACT: PER® MediaContacts

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhassoc.com

John Patricolo, 609-325-4630

jpatricolo@mjhassoc.com

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: HEALTH HOSPITALS ONCOLOGY OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE

SOURCE: Physicians’ Education Resource®

Copyright Business Wire 2019.

PUB: 05/06/2019 03:16 PM/DISC: 05/06/2019 03:16 PM

http://www.businesswire.com/news/home/20190506005686/en